Print

Biotech Day In Review: Novartis International AG (NVS) Pulls Zelnorm Off The Market  
4/2/2007 2:32:17 AM

Centient Biotech Investor submits: Novartis (NVS) suspended sales of Zelnorm, a treatment for irritable bowel syndrome with constipation, at the request of the FDA. The agency noticed a statistically significant number of cases of angina pectoris in patients taking the drug.

>>> Discuss This Story

//-->